New York City Mayor Eric Adams issues a statement in support of the EQUAL Act, ending the federal sentencing disparity between drug offenses involving crack cocaine and powder cocaine.
The report highlights the pressing financial and housing needs of people who use opioids surveyed across NYC during the first year of the COVID-19 pandemic.
The Mayor's Press Office releases information about notable events and actions taken by the Mayor, as well as transcripts of all media conferences, radio shows, and ceremonies that the Mayor attends.
Counts and rates of unintentional overdose deaths, stratified by demographic and geographic factors. In 2020, there were over 2,000 overdose deaths, an increase compared with 2019. Opioids were involved in 85% of overdose deaths.
This report provides updates to opioid training programs to certain individuals in administering opioid antagonists at the HRA’s HIV AIDS Services Administration (HASA) and the Department of Homeless Services.
Traffic on city streets is approaching pre-pandemic levels. With more traffic, comes more collisions & many of these accidents involve drivers impaired by alcohol or drugs. IBO looks at annual trends in the number of arrests of impaired drivers, as well as the number of collisions involving injuries
In accordance with the New York City Administrative Code §17-1001 (as amended by Local Law No. 19 of 2005), this report summarizes the Prescription Drug Discount Card Program, known as BigAppleRx, and is updated to include the period January 1, 2019 to December 31, 2019.
The Mayor's Press Office releases information about notable events and actions taken by the Mayor, as well as transcripts of all media conferences, radio shows, and ceremonies that the Mayor attends.
This brief presents provisional 2019 mortality data and describes demographic and geographic characteristics of drug overdose deaths, as well as trends over the past 20 years.
The NYC Municipal Drug Strategy Council (MDSC) is a body of government and community experts in substance use, with a shared goal to review and enhance New York City's drug strategy. This report includes a review of current drug strategy and progress, and recommendations for the future.